Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnpario Regulatory News (ANP)

Share Price Information for Anpario (ANP)

Share Price is delayed by 15 minutes
Get Live Data
520.00    5.00 (0.97%)
Bid:
510.00
Ask:
530.00
Spread: 20.00 (3.922%)
Market Cap: £85.47m
ANP Live PriceLast checked at - London Stock Exchange

Intraday Anpario Share Chart

Full year trading statement

10 Jan 2025 07:00

RNS Number : 8294S
Anpario PLC
10 January 2025
 

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

 

 

Anpario plc("Anpario", the "Group" or the "Company")

 

Full year trading statement

 

Anpario plc (AIM:ANP), the independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity, provides the following trading update for the year ended 31 December 2024 ("FY 2024"). The figures set out in this announcement remain subject to audit.

 

Trading update

The Group, including three months of trading for Bio-Vet Inc., delivered a stronger than expected operating performance in the second half of 2024. Year-end sales were higher than anticipated, and the Group now expects revenue for the 12 months ended 31 December 2024 to be approximately £37.5m* (31 December 2023: £31.0m). This strong performance in revenue combined with the Group's high operational gearing and favourable year-end foreign exchange movements, will result in adjusted EBITDA being ahead of current market expectations*.

 

Bio-Vet Inc. had a strong final quarter due to heightened demand for its products, which support the health of dairy cows affected by avian influenza, and our Middle East and Africa segment delivered an outstanding sales performance.

 

Financial position

Our financial position remains strong, with year-end cash balances of £10.5m* (31 December 2023: £10.6m), after accounting for the acquisition of Bio-Vet Inc. and associated land and buildings for an initial cash consideration of US$6.3m, on a debt-free basis, which completed in September 2024.

 

Our strong balance sheet enables the Group to invest in innovative natural product solutions, expand our global reach and explore earnings enhancing and complementary acquisitions to continue the profitable development of the Group. We remain confident in our ability to capitalise on growth opportunities, delivering long-term benefits to all stakeholders.

 

FY2024 Results

The Group expects to publish its FY 2024 final results on or around 26 March 2025.

 

 

 

*Analyst consensus for FY 2024 immediately prior to this announcement was Revenue of £35.25m, EBITDA of £5.7m and net cash of £7.2m.

 

Enquiries

 

Anpario plc

Richard Edwards, Chief Executive Officer

+44(0)7776 417 129

Marc Wilson, Group Finance Director

+44(0)1909 537 380

Shore Capital

 

(Nominated Adviser and Broker)

+44 (0) 20 7408 4090

Stephane Auton

Corporate Advisory

David Coaten

Tom Knibbs

Henry Willcocks

Corporate Broking

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUUUGUPAPWB
Date   Source Headline
23rd Oct 20087:00 amRNSAnglo Platinum Quarterly Review and Prod Report
23rd Sep 200812:00 pmRNSDirectorate Change
20th Aug 20089:42 amRNSDividend Declaration
1st Aug 20084:30 pmRNSDirector/PDMR Shareholding
28th Jul 20088:00 amRNSInterim Results
28th Jul 20088:00 amRNSAnglo Platinum Limited
23rd Jul 200812:32 pmRNSBlocklisting Interim Review
18th Jul 20082:32 pmRNSBlocklisting Interim Review
17th Jul 200812:15 pmRNSBlocklisting Interim Review
15th Jul 200811:19 amRNSBlocklisting Interim Review
14th Jul 200811:36 amRNSTrading Statement
2nd Jul 20083:07 pmRNSDirectorate Change
13th May 20089:34 amRNSDirectorate Change
13th May 20089:30 amRNSAnglo Platinum CEO
30th Apr 20082:31 pmRNSDividend Declaration
29th Apr 200811:25 amRNSNew order mining rights
29th Apr 200811:03 amRNSMining Rights Conversions
29th Apr 20087:00 amRNSFirst Quarter Review
2nd Apr 20087:00 amRNSFinal Results
11th Mar 20089:43 amRNSDividend conversion rate
10th Mar 20081:04 pmRNSRevised Conversion Price
7th Mar 20081:54 pmRNSDirector/PDMR Shareholding
7th Mar 20089:35 amRNSEmployee Share Scheme
15th Feb 20089:18 amRNSSmelter Shutdown
11th Feb 20087:00 amRNSFinal Results
11th Feb 20087:00 amRNSFinal Results
11th Feb 20087:00 amRNSAnglo Platinum
31st Jan 20089:50 amRNSPlatinum Transaction
31st Jan 20089:27 amRNSJoint Transaction
25th Jan 20085:38 pmRNSEnergy Supply Talks
23rd Jan 20082:24 pmRNSInterruption: Mine Production
23rd Jan 200811:07 amRNSDirectorate Change
17th Jan 20089:57 amRNSBlocklisting Interim Review
11th Jan 200812:16 pmRNSBlock listing application
16th Nov 20072:00 pmRNSAnglo Platinum Announcement
16th Nov 20071:56 pmRNSReduction in target
7th Nov 200710:12 amRNSProposed Transactions
2nd Nov 20072:00 pmRNSDirectorate Change
26th Oct 20073:02 pmRNSDividend Declaration
11th Oct 20071:00 pmRNSDirectorate Change
1st Oct 20073:03 pmRNSDirector/PDMR Shareholding
25th Sep 20077:01 amRNSInterim Results
4th Sep 20077:01 amRNSNotification
24th Aug 20073:23 pmRNSWage negotiations
22nd Aug 20079:09 amRNSDividend Conversion Rate
6th Aug 20074:13 pmRNSDirector/PDMR Shareholding
1st Aug 20077:02 amRNSChange of Adviser
30th Jul 200712:43 pmRNSDirectorate Change
30th Jul 20078:00 amRNSInterim Results
30th Jul 20078:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.